On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queensland Trade Commissioner to Japan), and Ms. Annu Tamura (Senior Business Development Manager) to Hirotsu Bioscience headquarters in Tokyo.
During their visit, details of the progress that has been made on cancer-specific screening and the N-NOSE project in Japan were shared including progress on the large-scale clinical study for N-NOSE that is currently underway by QUT in Australia.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29